Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models

Novel drug delivery systems are developed to improve the biological behavior of poorly soluble drugs and to improve therapeutic outcomes. In melanoma therapy, the goal is efficient drug delivery and mitigation of drug resistance. Melphalan (Mel), a currently used therapeutic agent for melanoma, requ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Nanomedicine
Main Authors: Michel, Deborah, Mohammed-Saeid, Waleed, Getson, Heather, Roy, Caitlin, Poorghorban, Masoomeh, Chitanda, Jackson M, Verrall, Ronald, Badea, Ildiko
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161338/
https://ncbi.nlm.nih.gov/pubmed/28003746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S121156
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados